Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

Study Purpose

To find good information about medullary thyroid cancer that is easy to understand and reliable, so researchers aim to design some new educational materials to help.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion criteria:

  • - Provision of signed and dated informed consent form.
  • - Males and females; Age: ≥18 years old.
  • - Identified ethnicity as "Hispanic" or "Latino/Latina" - Ability to read, write, and speak Spanish.
  • - Those who are pregnant are eligible to participate.
  • - Have or will face this decision, including: a.
Participant/survivor
  • - who has medullary thyroid carcinoma, as determined by a clinician or documented in Multi-Institutional Medullary Thyroid Cancer Collaborative Registry; b.
Caregiver/family member
  • - of Participant/survivor who has medullary thyroid carcinoma, as nominated by the Participant/survivor.

Exclusion Criteria:

  • - Those < age 18.
  • - Ethnic identity as non-Hispanic or non-Latino/a individual.
- Individuals with cognitive or psychological impairment (e.g., depression, anxiety, severe mental illness as documented in the registry

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT07142005
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

M.D. Anderson Cancer Center
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Elizabeth Grubbs, MD
Principal Investigator Affiliation [email protected]
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Not yet recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Medullary Thyroid Cancer (MTC), Cultural Adaptation
Study Website: View Trial Website
Additional Details

Primary Objectives. 1. To co-develop a culturally-adapted educational tool for the Latino/Latina MTC population using the previously developed MTCEducate.org as a framework. (Phase 1) 2. To test, refine, and produce a culturally adapted educational prototype and is intended to assess participants' understanding after reviewing the decision aid as part of the iterative testing and refinement process (Phase 2) Secondary Objectives. 1. To assess the tool's acceptability post-production among a broader population of Latino(a) MTC participants and caregivers using the Ottawa Acceptability Scale (Phase 3) 2. To disseminate the educational tool to a broader population of Latino(a)s. 3. To summarize the clinico-demographics of educational tool users

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

MD Anderson Cancer Center, Houston 4699066, Texas 4736286

Status

Address

MD Anderson Cancer Center

Houston 4699066, Texas 4736286, 77030

Site Contact

Elizabeth Grubbs, MD

[email protected]

713-792-0665

Stay Informed & Connected